A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

Human tuberculosis remains a significant cause of mortality and morbidity throughout the world. The global economic impact of bovine TB is considerable. An effective vaccine would be the most cost-effective way to control both epidemics, particularly in emerging economies. TB vaccine research would...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Pepponi, I, Khatri, B, Tanner, R, Villarreal-Ramos, B, Vordermeier, M, McShane, H
Formatua:	Journal article
Argitaratua:	Elsevier 2017

Antzeko izenburuak

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
nork: Brennan, M, et al.
Argitaratua: (2017)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
nork: Tanner, R, et al.
Argitaratua: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
nork: Tanner, R, et al.
Argitaratua: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 1; peer review: 2 approved]
nork: Rachel Tanner, et al.
Argitaratua: (2021-03-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
nork: Rachel Tanner, et al.
Argitaratua: (2021-09-01)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
nork: Painter, H, et al.
Argitaratua: (2024)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
nork: Tanner, R
Argitaratua: (2015)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
nork: Tanner, R, et al.
Argitaratua: (2020)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
nork: Painter, H, et al.
Argitaratua: (2024)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
nork: Hannah Painter, et al.
Argitaratua: (2024-02-01)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
nork: McShane, H, et al.
Argitaratua: (2016)

The humoral immune response to BCG vaccination
nork: Tanner, R, et al.
Argitaratua: (2019)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
nork: Rachel Tanner, et al.
Argitaratua: (2020-01-01)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
nork: Mcshane, H, et al.
Argitaratua: (2017)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
nork: Tanner, R, et al.
Argitaratua: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
nork: Marsay, L, et al.
Argitaratua: (2013)

The Humoral Immune Response to BCG Vaccination
nork: Rachel Tanner, et al.
Argitaratua: (2019-06-01)

Towards new TB vaccines
nork: Brazier, B, et al.
Argitaratua: (2020)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
nork: Tanner, R, et al.
Argitaratua: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
nork: Marsay, L, et al.
Argitaratua: (2013)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
nork: Tanner, R, et al.
Argitaratua: (2019)

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen
nork: Biffar, L, et al.
Argitaratua: (2019)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
nork: Dean, G, et al.
Argitaratua: (2014)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
nork: Fletcher, H, et al.
Argitaratua: (2013)

TB vaccines in clinical development
nork: Ginsberg, AM, et al.
Argitaratua: (2016)

A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity
nork: Emil Joseph Vergara, et al.
Argitaratua: (2024-07-01)

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
nork: Hyejon Lee, et al.
Argitaratua: (2019-04-01)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
nork: Vordermeier, H, et al.
Argitaratua: (2009)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
nork: Painter, H, et al.
Argitaratua: (2020)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
nork: Villarreal-Ramos, B, et al.
Argitaratua: (2017)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
nork: Hannah Painter, et al.
Argitaratua: (2020-02-01)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
nork: O'Shea, M, et al.
Argitaratua: (2018)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
nork: Dean, G, et al.
Argitaratua: (2014)

A review of clinical models for the evaluation of human TB vaccines.
nork: O'Shea, M, et al.
Argitaratua: (2016)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
nork: Vordermeier, H, et al.
Argitaratua: (2011)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
nork: Tanner, R, et al.
Argitaratua: (2021)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
nork: Vordermeier, H, et al.
Argitaratua: (2011)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
nork: Matthew K. O’Shea, et al.
Argitaratua: (2018-09-01)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
nork: Rachel Tanner, et al.
Argitaratua: (2021-01-01)

Immunological mechanisms of tuberculosis susceptibility in TB-infected individuals with type 2 diabetes mellitus: insights from mycobacterial growth inhibition assay and cytokine analysis
nork: Bindu Dasan, et al.
Argitaratua: (2025-01-01)